Home An Experimental Analysis of Patient Dumping Under Different Payment Systems
Article
Licensed
Unlicensed Requires Authentication

An Experimental Analysis of Patient Dumping Under Different Payment Systems

  • Massimo Finocchiaro Castro ORCID logo EMAIL logo , Domenico Lisi ORCID logo and Domenica Romeo ORCID logo
Published/Copyright: December 11, 2023

Abstract

Physicians behave differently depending on the payment systems, giving rise to several problems such as patient dumping in which patients are refused because of economic or liability reasons. This paper tests whether and to which extent the adoption of either fee-for-service or Salary system induces physicians to practice patient dumping. Through the combination of an artefactual field experiment and a laboratory experiment, we test whether the risk of being sued for having practiced dumping can affect physicians’ behavior. Dumping is more often observed under Salary than under FFS. The introduction of dumping liability only mildly reduced dumping practice, though the provision of services increased. Our findings call for healthcare policy makers looking at the interplay between remuneration schemes and liability risks, and accounting for the trade-off between the reduction of the risk of being sued for patient dumping and the increase of the costs of the provision of medical services.

JEL Classification: C72; C93; D83; I12

Corresponding author: Massimo Finocchiaro Castro, Department of Law, Economics and Social Science, Mediterranean University of Reggio Calabria, Reggio Calabria, Italy; Health Econometrics and Data Group, University of York, York, UK; and Institute for Corruption Studies, Illinois State University, Normal, USA, E-mail:

Acknowledgments

We thankfully acknowledge valuable feedback from the editor Prof. Sandra Ludwig, two anonymous referees, and Peter Martinsson, Mariana Blanco and Calogero Guccio. We would like to thank participants at the EUHEA Conference 2022 in Oslo, in particular Johanna Kokot, Luigi Siciliani, Matteo Lippi Bruni and Mathias Kifmann, for their helpful comments. Finally, we are grateful to the G.O.M. Grande Ospedale Metropolitano in Reggio Calabria, in the persons of Francesco Araniti and Giuseppina Albanese.

Appendix A: Theory Model in Explicit Form

In this Appendix, we revisit the theoretical model in Section 3 by using the explicit functional forms employed in the experiment. Although less general, this revisitation sheds more light on the link between the theory of physicians’ behavior and the choice setting for participants in the experiment.

Physician’s profit can be represented as follows:

Π q = p q c q 2 under FFS L c q 2 under Salary

where p is the fee for each medical service provided under FFS, L is the fixed salary paid under the Salary system, and c is the marginal cost parameter.

Patient’s benefit resulting from medical treatment is given by B q , j + ε , where ɛ refers to the random component (due to the unavoidable uncertainty surrounding the provision of medical care) following a standard logistic distribution, ɛ ∼ Logistic(0, 1). The deterministic component of patients’ benefit is given by:

B j q = B 0 j + q if q q * B 1 j q if q q *

with B 0 j = 1 = 7 , B 0 j = 2 = 5 , B 0 j = 3 = 3 and B 1 j = B 0 j + 2 q * . The optimal quantities of medical services are thus given by q* = 3 for low (j = 1), q* = 5 for intermediate (j = 2), and q* = 7 for high severity (j = 3).

The probability of being sued for medical malpractice is given by:

P r j q = λ j 1 q 10

in which λ j=1 = 0.3, λ j=2 = 0.4, and λ j=3 = 0.5. Therefore, for each quantity of medical services, a higher severity (i.e. from low to intermediate, as well as from intermediate to high severity) increases the probability of being sued for malpractice of 10 %, that is:

Pr j j = 0.1

Finally, the probability of being sued for dumping is given by d j = 1 = 0.1 , d j = 2 = 0.15 , d j = 3 = 0.2 . This implies that a higher severity (i.e. from low to intermediate, as well as from intermediate to high severity) increases the probability of being sued for dumping of 5 %, that is:

d j j = 0.05

Considering the above explicit function forms, the physician’s utility functions under FFS and Salary system, respectively, are given as follows:

U q FFS = if patient is treated p q c q 2 + α B 0 j + q λ j 1 q 10 H + ε if patient is dumped d j D

U q Salary = if patient is treated L c q 2 + α B 0 j + q λ j 1 q 10 H + ε if patient is dumped L d j D

where α ∈ [0, 1] measures the rate at which the physician is willing to give up one euro of profit for one euro of patient benefit. Then, H is the disutility coming from a malpractice litigation; similarly, D is the disutility coming from complaints for patient dumping.

Physicians facing a patient make two sequential choices:

  • 1) they decide if taking charge of the patient or dumping him.

  • 2) in case of admission, they choose the quantity of medical services to provide.

As usual in sequential choice models, we solve the model through backward induction (i.e. starting from the last decision to be made and then going backwards).

In case of a patient being treated, the first order conditions for the optimal quantity of medical services under the two payment systems, q FFS * and q Salary * , are given by:

U q FFS q = p 2 c q FFS * + α + λ j 10 H = 0

U q Salary q = 2 c q Salary * α + λ j 10 H = 0

which imply that

q FFS * = p + α + λ j 10 H 2 c

q Salary * = α + λ j 10 H 2 c

Hence, in case of a patient being treated, we have that q FFS * > q Salary * (Behavioral Hypothesis 3).

Then, going backwards at the second-to-last decision, the physician chooses to treat patient j over to dump him provided that U if patient is treated > U if patient is dumped , that is:

Pr treat j FFS = Pr p q c q 2 + α B 0 j + q λ j 1 q 10 H + ε > d j D = Pr ε < p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D = e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 1 + e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D

Pr treat j Salary = Pr L c q 2 + α B 0 j + q λ j 1 q 10 H + ε > L j D = Pr ε < c q 2 + α B 0 j + q λ j 1 q 10 H + j D = e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 1 + e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D

where we exploit the fact that ε Logistic 0,1 . These represent the probabilities for patient j of receiving treatment (i.e. not being dumped) under FFS and Salary system, respectively.

Comparing the above probabilities of being treated, we can thus investigate the impact of the payment system on the physicians’ practice of patient dumping. For each q, it is immediate to see that Pr treat j FFS > Pr treat j Salary , in fact:

e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 1 + e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D > e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 1 + e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D

e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D > e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D

p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D > c q 2 + α B 0 j + q λ j 1 q 10 H + d j D

p q > 0

Moreover, physicians choose a higher level of services under FFS, q FFS * > q Salary * , which implies that the probability of facing a malpractice litigation should be lower under FFS, further reducing the incentive to dump patients in FFS with respect to the Salary system. Therefore, the level of dumping achieved under Salary is higher than the one reached under FFS (Behavioral Hypothesis 1).

Then, we can examine whether the introduction of dumping liability affects physicians’ attitude toward dumping. Differentiating the probability of being treated in the two payment systems, we get:

Pr treat j FFS d = Pr treat j FFS D 1 + e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D > 0

Pr treat j Salary d = Pr treat j Salary D 1 + e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D > 0

Hence, when physicians can be sued for dumping, the probability of treating patient j should increase, and thus the level of dumping decrease in both payment systems (Behavioral Hypothesis 2).

Differentiating with respect to j, we can also inspect how the probability of being admitted, and thereby the dumping practice, changes with respect to the degree of patient severity:

Pr { treat j } FFS j = Pr treat j FFS p 0.02 c H 2 c q 0.02 c H + α 0.02 c H 2 H 1 q 10 λ j 1 0.01 c + 0.05 D 1 + e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 0

Pr { treat j } Salary j = Pr treat j Salary 2 c q 0.02 c H + α 0.02 c H 2 H 1 q 10 λ j 1 0.01 c + 0.05 D 1 + e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 0

Therefore, we can see that how dumping practice changes with respect to j is highly ambiguous.

Finally, integrating Pr treat j over the distribution f j of patient’s severity in the population, we obtain the equilibrium level of dumping as a proportion of patients being dumped in the population:

Dumping FFS = 1 j e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 1 + e p q c q 2 + α B 0 j + q λ j 1 q 10 H + d j D f j d j

Dumping Salary = 1 j e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D 1 + e c q 2 + α B 0 j + q λ j 1 q 10 H + d j D f j d j

These equations give us the equilibrium level of dumping as a function of the physicians’ payment system (i.e. either FFS or Salary), as well as the risk of being sued for both malpractice and dumping.

Appendix B: Instructions

Welcome to Our Experiment

You are going to join an experiment on individual decision-making. Instructions are straightforward and, if you pay close attention, you may gain a monetary amount that will be paid to you in corresponding meal tickets at the end of the experiment. The amount of cash you may win depends only on your decisions and will not be affected by other participants’ decisions. Your monetary gains, measured in Experimental Crown (EC), will be converted into Euro at the following exchange rate 1 EC = 0.45 Euro. For example, if, at the end of the experiment, you achieve 40 EC, you will receive a 18 Euro meal ticket.

Experimental Design

The experiment lasts approximately 30 min and is divided into two stages. You will receive detailed instructions at the beginning of each stage. Please, remind that the decisions taken in one stage of the experiment do not have effects on the decisions that you will have to take in the following stage of the experiment.

Stage I

Please, read carefully the following instructions regarding stage I. If anything in the instructions is not clear please raise your hand and one of the experimenters will approach you. From this moment onward, you cannot communicate with any other participant. If you fail to do so, you will be asked to leave the room.

Stage I lasts for nine periods. In each period, you will play in the role of a physician and you will have to decide whether to take charge of an already diagnosed patient. In each period you will face a patient with a different diagnosis. Each diagnosis is associated with a different level of severity of illness (low, medium, high).

Figure B.1: 
Example situation. Screenshot from z-Tree.
Figure B.1:

Example situation. Screenshot from z-Tree.

If you decide to treat the patient you then have to decide how many medical prescriptions to provide to patients. In other words, you have to decide on the level of medical care (in terms of drugs, diagnostic exams, …) to provide to patients according to their severity of illness. Thus, you will face nine patients. When taking the decision on patient’s medical care, you can choose among 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 prescriptions per patient. If you decide not to treat the patient you will skip to the following period. If you decide otherwise to treat the patient, after the decision on the level of medical prescriptions to provide, the patient could sue you for medical malpractice with probability Pr, which depends on the level of medical prescriptions already provided.

The following table shows the relationship between patient’s severity of illness and your profit, if you decide not to treat the patient.

Severity of illness Your profit
Low (1) 0
Medium (2) 0
High (3) 0

The other tables we will provide before taking your decision, show the relationship between provided prescriptions and the probability of being sued.

Earnings

In each period of stage I, you will be paid according to the FFS payment system. Your earnings increase together with the number of medical prescriptions that you provide to patients. Moreover, you bear a cost due to the level of effort devoted to visiting each patient that depends on how many medical prescriptions you provide to patients. If you get sued by a patient, you will incur a fixed monetary loss equal to the profits earned in the same period you are sued. Hence, your profit in each period is computed as the payment you receive from the FFS system minus the cost due to the provision of medical services minus, if sued, the monetary loss due to being sued by the patient.

Each level of medical prescription provided accrues a certain level of benefit to patient according to her/his severity of illness. Therefore, your choice on the quantity of medical prescriptions to provide determines both your profits and the patients’ benefits.

In each period, you will see on the screen (see below) all the information regarding the patient you currently face: his diagnosis, the associated severity of illness, your earning according to the payment system in use, the related costs, the probability of being sued for each possible level of medical prescriptions, the monetary loss due to being sued, your profits and the corresponding patient’s benefits.

Stage II

Please, read carefully the following instructions regarding stage I. If anything in the instructions is not clear please raise your hand and one of the experimenters will approach you. From this moment onward, you cannot communicate with any other participant. If you fail to do so, you will be asked to leave the room.

Stage II lasts for nine periods. In each period, you will play in the role of a physician and you will have to decide whether to take charge of an already diagnosed patient. In each period you will face a patient with a different diagnosis. Each diagnosis is associated with a different level of severity of illness (low, medium, high). If you decide to treat the patient you then have to decide how many medical prescriptions to provide to patients. In other words, you have to decide on the level of medical care (in terms of drugs, diagnostic exams, …) to provide to patients according to their severity of illness. Thus, you will face nine patients. When taking the decision on patient’s medical care, you can choose among 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 prescriptions per patient.

If you decide not to treat the patient, before skipping to the following period, you may be sued with probability d, which depends on the patient’s severity of illness. If you decide otherwise to treat the patient, after the decision on the level of medical prescriptions to provide, the patient could sue you for medical malpractice with probability Pr, which depends on the level of medical prescriptions already provided.

The following table shows the relationship between the probability of being sued for not treating the patient, d, and the patient’s severity of illness.

Severity of illness Probability d Your profit
Low (1) 10 % −10
Medium (2) 15 % −10
High (3) 20 % −10

Earnings

In each period of stage II, you will be paid according to the FFS payment system. Your earnings increase together with the number of medical prescriptions that you provide to patients. Moreover, you bear a cost due to the level of effort devoted to visiting each patient that depends on how many medical prescriptions you provide to patients. If you decide not to treat the patient and you get sued for that, you will incur a loss as shown in table and your profit will be simply equal to it. If you decide to treat the patient and you get sued by a patient for malpractice, you will incur a fixed monetary loss equal to the profits earned in the same period you are sued. Hence, if you treat the patient, your profit in each period is computed as the payment you receive from the FFS system minus the cost due to the provision of medical services minus, if sued, the monetary loss due to being sued by the patient.

Each level of medical prescription provided accrues a certain level of benefit to patient according to her/his severity of illness. Therefore, your choice on the quantity of medical prescriptions to provide determines both your profits and the patients’ benefits.

In each period, you will see on the screen (see below) all the information regarding the patient you currently face: his diagnosis, the associated severity of illness, your earning according to the payment system in use, the related costs, the probability of being sued for each possible level of medical prescriptions, the monetary loss due to being sued, your profits and the corresponding patient’s benefits.

Patient with illness 1:

Patient with illness 2:

Patient with illness 3:

Stage I (for a Different Pool)

Please, read carefully the following instructions regarding stage I. If anything in the instructions is not clear please raise your hand and one of the experimenters will approach you. From this moment onward, you cannot communicate with any other participant. If you fail to do so, you will be asked to leave the room.

Stage I lasts for nine periods. In each period, you will play in the role of a physician and you will have to decide whether to take charge of an already diagnosed patient. In each period you will face a patient with a different diagnosis. Each diagnosis is associated with a different level of severity of illness (low, medium, high). If you decide to treat the patient you then have to decide how many medical prescriptions to provide to patients. In other words, you have to decide on the level of medical care (in terms of drugs, diagnostic exams, …) to provide to patients according to their severity of illness. Thus, you will face nine patients. When taking the decision on patient’s medical care, you can choose among 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 prescriptions per patient.

If you decide not to treat the patient you will skip to the following period. If you decide otherwise to treat the patient, after the decision on the level of medical prescriptions to provide, the patient could sue you for medical malpractice with probability Pr, which depends on the level of medical prescriptions already provided.

The following table shows the relationship between patient’s severity of illness and your profit, if you decide not to treat the patient.

Severity of illness Your profit
Low (1) 10
Medium (2) 10
High (3) 10

The other tables we will provide before taking your decision, show the relationship between provided prescriptions and the probability of being sued.

Earnings

In each period of Stage I, you will be given a fixed salary. Your remuneration does not vary with the quantity of medical services provided. Your profit in each period is computed as your fixed salary equal to 10, minus the cost due to the provision of medical services if you treat the patient, minus, if sued, the monetary loss due to being sued by the patient.

Each level of medical prescription provided accrues a certain level of benefit to patient according to her/his severity of illness. Therefore, your choice on the quantity of medical prescriptions to provide determines both your profits and the patients’ benefits.

In each period, you will see on the screen (see below) all the information regarding the patient you currently face: his diagnosis, the associated severity of illness, your earning according to the payment system in use, the related costs, the probability of being sued for each possible level of medical prescriptions, the monetary loss due to being sued, your profits and the corresponding patient’s benefits.

Stage II (for a Different Pool)

Please, read carefully the following instructions regarding stage I. If anything in the instructions is not clear please raise your hand and one of the experimenters will approach you. From this moment onward, you cannot communicate with any other participant. If you fail to do so, you will be asked to leave the room.

Stage II lasts for nine periods. In each period, you will play in the role of a physician and you will have to decide whether to take charge of an already diagnosed patient. In each period you will face a patient with a different diagnosis. Each diagnosis is associated with a different level of severity of illness (low, medium, high). If you decide to treat the patient you then have to decide how many medical prescriptions to provide to patients. In other words, you have to decide on the level of medical care (in terms of drugs, diagnostic exams, …) to provide to patients according to their severity of illness. Thus, you will face nine patients. When taking the decision on patient’s medical care, you can choose among 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 prescriptions per patient.

If you decide not to treat the patient, before skipping to the following period, you may be sued with probability d, which depends on the patient’s severity of illness. If you decide otherwise to treat the patient, after the decision on the level of medical prescriptions to provide, the patient could sue you for medical malpractice with probability Pr, which depends on the level of medical prescriptions already provided.

The following table shows the relationship between the probability of being sued for not treating the patient, d, and the patient’s severity of illness.

Severity of illness Probability d Profit
Low (1) 10 % 0
Medium (2) 15 % 0
High (3) 20 % 0

The other tables we will provide before taking your decision, show the relationship between provided prescriptions and the probability of being sued.

Earnings

In each period of Stage II, you will be given a fixed salary. Your remuneration does not vary with the quantity of medical services provided. If you decide not to treat the patient and you get sued for that, you will incur a loss as shown in table and your profit will be simply equal to it. Otherwise, your profit in each period is computed as your fixed salary equal to 10, minus the cost due to the provision of medical services if you treat the patient, minus, if sued, the monetary loss due to being sued by the patient.

Each level of medical prescription provided accrues a certain level of benefit to patient according to her/his severity of illness. Therefore, your choice on the quantity of medical prescriptions to provide determines both your profits and the patients’ benefits.

In each period, you will see on the screen (see below) all the information regarding the patient you currently face: his diagnosis, the associated severity of illness, your earning according to the payment system in use, the related costs, the probability of being sued for each possible level of medical prescriptions, the monetary loss due to being sued, your profits and the corresponding patient’s benefits.

Payment

At the end of the experiment, for each session, one period will be randomly drawn. The profit achieved in that period will be paid to you in corresponding meal tickets. While you in this stage have decided in the role of physician on service provision for hypothetical patients, real patients’ health outside the lab is affected by your choices. The overall benefits accruing to patients will be converted into Euro and donated to the charity ‘Per Mano onlus’, https://permanoonlus.wixsite.com/per-mano-onlus. To verify that the monetary amount corresponding to the sum of the patients’ benefits in a session is transferred, one of the subjects will be randomly chosen to be a monitor. When the experiment is over, the monitor will verify that one of the experimenters will transfer the monetary amount through credit card payment on the Per Mano ONLUS website. The money will support the charity assisting people affected by Duchenne Muscular Dystrophy.

Questionnaire

Before starting the experiment, we kindly ask you to answer some simple questions aiming at checking your comprehension of the design of stage I and of the profit generation mechanism.

If you have any question regarding the questionnaire, please raise your hand and one of the experimenters will come to your seat. Stage I will start only when all the participants answer to all questions correctly.

Table C.1:

Parameter values.

Quantity (q)
Treatment Variable 0 1 2 3 4 5 6 7 8 9 10
FFS R FFS 0 2 4 6 8 10 12 14 16 18 20
Salary R Salary 10 10 10 10 10 10 10 10 10 10 10
all c 0 0.1 0.4 0.9 1.6 2.5 3.6 4.9 6.4 8.1 10
FFS π 0 1.9 3.6 5.1 6.4 7.5 8.4 9.1 9.6 9.9 10
Salary π 10 9.9 9.6 9.1 8.4 7.5 6.4 5.1 3.6 1.9 0
all Pr j=1 30 % 27 % 24 % 21 % 18 % 15 % 12 % 9 % 6 % 3 % 0 %
Pr j=2 40 % 36 % 32 % 28 % 24 % 20 % 16 % 12 % 8 % 4 % 0 %
Pr j=3 50 % 45 % 40 % 35 % 30 % 25 % 20 % 15 % 10 % 5 % 0 %
all B j=1 7 8 9 10 9 8 7 6 5 4 3
B j=2 5 6 7 8 9 10 9 8 7 6 5
B j=3 3 4 5 6 7 8 9 10 9 8 7
Patient dumping (d j=1  = 10 %; d j=2  = 15 %; d j=3  = 20 %)
FFS with d.l. π if not sued 0 0 0 0 0 0 0 0 0 0 0
Salary with d.l. π if not sued 10 10 10 10 10 10 10 10 10 10 10
FFS with d.l. π if sued −10 −10 −10 −10 −10 −10 −10 −10 −10 −10 −10
Salary with d.l. π if sued 0 0 0 0 0 0 0 0 0 0 0
  1. FFS, fee-for-service; R, revenue; C, total cost; π, profit; Pr, probability of being sued for malpractice; B, patients’ health benefit; d, probability of being sued for dumping.

Regressions reported in Table D.1 focus on the deviation from the efficient quantity, by participants’ type.[37] Specifically, following the extensive literature on health economics (e.g. Brosig-Koch et al. 2017; Chalkley and Malcomson 1998; Ellis and McGuire 1986, 1990; Ma and Mak 2015), the efficient quantities of medical services in our experiment are implicitly defined by Δ B q E = Δ C q E ; therefore, they are equal to q E  = 3 for low x and q E  = 5 for medium y and high z severities.

Table D.1:

Deviation from the efficient quantity ( q q e ) by participants’ type.

Physicians (n = 36) Students (n = 64)
(1) (2) (3) (1) (2) (3)
2.degreeofillness −0.313 −0.211 −0.335 −0.464*** 0.0753 0.0839
(0.300) (0.306) (0.279) (0.149) (0.180) (0.180)
3.degreeofillness 0.413 0.547* 0.429 1.003*** 2.385*** 2.395***
(0.318) (0.310) (0.279) (0.258) (0.260) (0.260)
FFS 0.954* 1.154* 0.991 1.505*** 1.109** 1.387***
(0.541) (0.642) (0.687) (0.362) (0.447) (0.478)
Dumping 0.380*** 0.349*** 0.521*** 0.238** −0.0227 0.139
(0.0825) (0.0867) (0.127) (0.117) (0.171) (0.221)
Age 0.0251 0.0189 0.198* 0.253**
(0.0291) (0.0236) (0.0982) (0.102)
Male 0.493 1.392** −0.849* −1.182**
(0.647) (0.603) (0.447) (0.461)
Emergency department −0.646 −0.334
(0.685) (0.692)
Riskseekinga −0.0914 0.752 1.079 −0.0204
(0.680) (0.747) (0.800) (0.483)
Male*Riskseeking −2.207* 2.809***
(1.109) (0.618)
FFS*Dumping −0.263 −0.306
(0.179) (0.339)
Constant −0.704 −1.925* −2.021** 0.381 −4.459* −5.657**
(0.475) (1.066) (0.942) (0.230) (2.180) (2.253)
Observations 500 483 483 1075 457 457
  1. Clustered standard errors at the individual level in parentheses; ***p < 0.01, **p < 0.05, *p< 0.1. 2.degreeofillness and 3.degreeofillness are dummy variables equal to 1 if patient’s severity of illness is either intermediate or high and 0 if the severity is low. FFS is a dummy variable equal to 1 if subjects are paid by FFS and 0 if they are paid by Salary. Dumping is a dummy variable equal to 1 if subjects joined a session where dumping liability has been implemented and 0 otherwise. Male is a dummy variable equal to 1 if the subject is male and 0 otherwise. Physician is a dummy variable equal to 1 if the subject is a physician and 0 otherwise. Emergency department is a dummy variable equal to 1 if the physician works at the Emergency department and 0 otherwise. Riskseeking is a dummy variable equal to 1 if the subject is classified as risk-lover according to Holt and Laury (2002)’s questionnaire and 0 otherwise. aThe lower number of observations is due to the exclusion of subjects whose inconsistent choices in the HL questionnaire have prevented them from being classified as either risk-seeker, risk-neutral or risk-averse.

Overprovision is more often observed for high severity patients. Additionally, the deviation from the efficient quantity increases under FFS. However, physicians show a more optimizing behavior than students, balancing patient’s health benefit and treatment costs. Physicians working in the hospital, in fact, always face the trade-off between benefits and costs of each treatment decision. Also dumping liability is found to increase the deviation from the efficient quantity; however, as usually found in the analysis, dumping liability is more salient to physicians.

References

Agenzia di Sanità pubblica Regione Lazio. 2002. Criteri clinico-organizzativi per il trasferimento del paziente critico nella rete dell’emergenza. Lazio: ASP Monografie.Search in Google Scholar

Ahlert, M., S. Felder, and B. Vogt. 2012. “Which Patients Do I Treat? An Experimental Study with Economists and Physicians.” Health Economics Review 2 (1): 1–11.10.1186/2191-1991-2-1Search in Google Scholar

Asprone, E. 2015. “Diritto Penale. Il rifiuto da parte del medico del ricovero ospedaliero del malato in condizioni d’urgenza integra il reato di rifiuto d’atti d’ufficio.” In Gazzetta Forense, http://www.gazzettaforense.com/2015/02/25/diritto-penale-il-rifiuto-da-parte-del-medico-del-ricovero-ospedaliero-del-malato-in-condizioni-durgenza-integra-il-reato-di-rifiuto-datti-dufficio/.Search in Google Scholar

Avraham, R., and M. Schanzenbach. 2015. “The Impact of Tort Reform on Intensity of Treatment: Evidence from Heart Patients.” Journal of Health Economics 39: 273–88. https://doi.org/10.1016/j.jhealeco.2014.08.002.Search in Google Scholar

Baicker, K., E. S. Fisher, and A. Chandra. 2007. “Malpractice Liability Costs and the Practice of Medicine in the Medicare Program.” Health Affairs 26 (3): 841–52. https://doi.org/10.1377/hlthaff.26.3.841.Search in Google Scholar

Bertoli, P., and V. Grembi. 2018. “Medical Malpractice: How Legal Liability Affects Medical Decisions.” In Health Econometrics, 235–61. Leeds: Emerald Publishing Limited.10.1108/S0573-855520180000294011Search in Google Scholar

Blomqvist, A., and C. Busby. 2012. “How to Pay Family Doctors: Why ‘Pay Per Patient’ is Better than Fee for Service.” CD Howe Institute Commentary, Vol. 365, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2172035.10.2139/ssrn.2172035Search in Google Scholar

Brañas-Garza, P., L. Estepa-Mohedano, D. Jorrat, V. Orozco, and E. Rascón-Ramírez. 2021. “To Pay or Not to Pay: Measuring Risk Preferences in Lab and Field.” Judgment and Decision Making 16 (5): 1290–313. https://doi.org/10.1017/s1930297500008433.Search in Google Scholar

Brosig-Koch, J., H. Hennig Schmidt, N. Kairies-Schwarz, and D. Wiesen. 2016. “Using Artefactual and Lab Experiments to Investigate How Fee-For-Service and Capitation Affect Medical Service Provision.” Journal of Economic Behavior & Organization 131: 17–23. https://doi.org/10.1016/j.jebo.2015.04.011.Search in Google Scholar

Brosig-Koch, J., H. Hennig Schmidt, N. Kairies-Schwarz, and D. Wiesen. 2017. “The Effect of Introducing Mixed Payment Systems for Physician: Experimental Evidence.” Health Economics 26: 243–62. https://doi.org/10.1002/hec.3292.Search in Google Scholar

Brosig-Koch, J., M. Groß, H. Hennig‐Schmidt, N. Kairies-Schwarz, and D. Wiesen. 2021. Physicians’ Incentives, Patients’ Characteristics, and Quality of Care a Systematic Experimental Comparison of Fee-For-Service, Capitation, and Pay for Performance. https://ssrn.com/abstract=4168743.10.2139/ssrn.4168743Search in Google Scholar

Brosig-Koch, J., H. Hennig‐Schmidt, N. Kairies-Schwarz, J. Kokot, and D. Wiesen. 2023. A New Look at Physicians’ Responses to Financial Incentives: Quality of Care, Practice Characteristics, and Motivations. https://ssrn.com/abstract=4366378.10.2139/ssrn.4366378Search in Google Scholar

Busse, R., J. Schreyögg, and P. C. Smith. 2006. “Hospital Case Payment Systems in Europe.” Health Care Management Science 9 (3): 211–3. https://doi.org/10.1007/s10729-006-9039-7.Search in Google Scholar

Cameron, A. C., J. B. Gelbach, and D. L. Miller. 2008. “Bootstrap-Based Improvements for Inference with Clustered Errors.” The Review of Economics and Statistics 90 (3): 414–27. https://doi.org/10.1162/rest.90.3.414.Search in Google Scholar

Chalkley, M., and J. M. Malcomson. 1988. “Contracting for Health Services When Patient Demand Does Not Reflect Quality.” Journal of Health Economics 17 (1): 1–19, https://doi.org/10.1016/s0167-6296(97)00019-2.Search in Google Scholar

Chalkley, M., and Malcomson, J. M. 1998. “Contracting for health services with unmonitored quality.” The Economic Journal 108 (449): 1093–110.10.1111/1468-0297.00331Search in Google Scholar

Chandra, A., D. Cutler, and Z. Song. 2011. “Who Ordered That? The Economics of Treatment Choices in Medical Care.” In Handbook of Health Economics, 2, edited by V. Mark, T. G. M. Pauly, and P. P. Barros, 397–432. Oxford: Elsevier.10.1016/B978-0-444-53592-4.00006-2Search in Google Scholar

Charness, G., U. Gneezy, and M. A. Kuhn. 2012. “Experimental Methods: Between-Subject and Within-Subject Design.” Journal of Economic Behavior and Organization 81: 1–8. https://doi.org/10.1016/j.jebo.2011.08.009.Search in Google Scholar

Clemens, J., and J. D. Gottlieb. 2014. “Do Physicians’ Financial Incentives Affect Medical Treatment and Patient Health?” American Economic Review 104 (4): 1320–49. https://doi.org/10.1257/aer.104.4.1320.Search in Google Scholar

Cohen, S. J., M. Weinberger, S. A. Mazzuca, and C. J. McDonald. 1982. “Perceived Influence of Different Information Sources on the Decision-Making of Internal Medicine House Staff and Faculty.” Social Science & Medicine 16 (14): 1361–4. https://doi.org/10.1016/0277-9536(82)90032-6.Search in Google Scholar

Cragg, J. G. 1971. “Some Statistical Models for Limited Dependent Variables with Application to the Demand for Durable Goods.” Econometrica 39 (5): 829–44, https://doi.org/10.2307/1909582.Search in Google Scholar

Cupelli, C. 2017. “Lo statuto penale della colpa medica e le incerte novità della legge Gelli-Bianco.” Diritto Penale Contemporaneo 4: 200–16.Search in Google Scholar

Currie, J., and W. B. MacLeod. 2008. “First Do Not Harm? Tort Reform and Birth Outcomes.” The Quarterly Journal of Economics 123 (2): 795–830. https://doi.org/10.1162/qjec.2008.123.2.795.Search in Google Scholar

Danzon, P. M. 2000. “Liability for Medical Malpractice.” In Handbook of Health Economics, edited by A. J. Culyer, and J. P. Newhouse. (Chapter 26), 1339–404. Oxford: Elsevier.10.1016/S1574-0064(00)80039-6Search in Google Scholar

Donaldson, C., and K. Gerard. 1989. “Paying General Practitioners: Shedding Light on the Review of Health Services.” The Journal of the Royal College of General Practitioners 39 (320): 114–7.Search in Google Scholar

Dranove, D. 1987. “Rate-Setting by Diagnosis Related Groups and Hospital Specialization.” The RAND Journal of Economics 18 (3): 417–27, https://doi.org/10.2307/2555606.Search in Google Scholar

Ellis, R. P. 1998. “Creaming, Skimping and Dumping: Provider Competition on the Intensive and Extensive Margins.” Journal of Health Economics 17 (5): 537–55. https://doi.org/10.1016/s0167-6296(97)00042-8.Search in Google Scholar

Ellis, R. P., and T. G. McGuire. 1986. “Provider Behavior under Prospective Reimbursement: Cost Sharing and Supply.” Journal of Health Economics 5 (2): 129–51. https://doi.org/10.1016/0167-6296(86)90002-0.Search in Google Scholar

Ellis, R. P., and T. G. McGuire. 1990. “Optimal Payment Systems for Health Services.” Journal of Health Economics 9 (4): 375–96. https://doi.org/10.1016/0167-6296(90)90001-j.Search in Google Scholar

Eze, P., and B. Wolfe. 1993. “Is Dumping Socially Inefficient? An Analysis of the Effect of Medicare’s Prospective Payment System on the Utilization of Veterans Affairs Inpatient Services.” Journal of Public Economics 52 (3): 329–44. https://doi.org/10.1016/0047-2727(93)90038-u.Search in Google Scholar

Finocchiaro Castro, M., P. Ferrara, C. Guccio, and D. Lisi. 2019. “Medical Malpractice Liability and Physicians’ Behavior: Experimental Evidence.” Journal of Economic Behavior & Organization 166: 646–66. https://doi.org/10.1016/j.jebo.2019.08.006.Search in Google Scholar

Finocchiaro Castro, M., C. Guccio, and D. Romeo. 2022. A Systematic Literature Review of 10 Years of Behavioral Research on Health Services. Kiel: ZBW – Leibniz Information Centre for Economics. http://hdl.handle.net/10419/266248.Search in Google Scholar

Fischbacher, U. 2007. “z-Tree: Zurich Toolbox for Ready-Made Economic Experiments.” Experimental Economics 10 (2): 171–8. https://doi.org/10.1007/s10683-006-9159-4.Search in Google Scholar

France, G., F. Taroni, and A. Donatini. 2005. “The Italian Health‐Care System.” Health Economics 14 (S1): S187–S202. https://doi.org/10.1002/hec.1035.Search in Google Scholar

Gabriele, S. 2019. Lo stato della sanità in Italia. Focus n. 6, Ufficio parlamentare di bilancio.Search in Google Scholar

Galizzi, M. M., M. Miraldo, and C. Stavropoulou. 2016. “In Sickness but not in Wealth: Field Evidence on Patients’ Risk Preferences in Financial and Health Domains.” Medical Decision Making 36 (4): 503–17. https://doi.org/10.1177/0272989x15626406.Search in Google Scholar

Gneezy, U., and A. Rustichini. 2000. “Pay Enough or Don’t Pay at All.” The Quarterly Journal of Economics 115 (3): 791–810. https://doi.org/10.1162/003355300554917.Search in Google Scholar

Green, P. E. 2014. “Payment Systems in the Healthcare Industry: An Experimental Study of Physicians’ Incentives.” Journal of Economic Behavior & Organization 106: 367–78. https://doi.org/10.1016/j.jebo.2014.05.009.Search in Google Scholar

Guccio, C., and D. Lisi. 2016. “Thus Do All. Social Interactions in Inappropriate Behavior for Childbirth Services in a Highly Decentralized Healthcare System.” Regional Science and Urban Economics 61: 1–17. https://doi.org/10.1016/j.regsciurbeco.2016.08.004.Search in Google Scholar

Heckman, J. J. 1979. “Sample Selection Bias as a Specification Error.” Econometrica 47 (1): 153–61, https://doi.org/10.2307/1912352.Search in Google Scholar

Hennig Schmidt, H., R. Selten, and D. Wiesen. 2011. “How Payment Systems Affect Physicians’ Provision Behaviour: An Experimental Investigation.” Journal of Health Economics 30: 637–46. https://doi.org/10.1016/j.jhealeco.2011.05.001.Search in Google Scholar

Hennig-Schmidt, H., and D. Wiesen. 2014. “Other-Regarding Behavior and Motivation in Health Care Provision: An Experiment with Medical and Non-Medical Students.” Social Science and Medicine 108: 156–65.10.1016/j.socscimed.2014.03.001Search in Google Scholar

Holt, C. A., and S. K. Laury. 2002. “Risk Aversion and Incentive Effects.” American Economic Review 92 (5): 1644–55. https://doi.org/10.1257/000282802762024700.Search in Google Scholar

Iannello, P., V. Perucca, S. Riva, A. Antonietti, and G. Pravettoni. 2015. “What Do Physicians Believe about the Way Decisions Are Made? A Pilot Study on Metacognitive Knowledge in the Medical Context.” Europe’s Journal of Psychology 11 (4): 691. https://doi.org/10.5964/ejop.v11i4.979.Search in Google Scholar

Jena, A. B., S. Seabury, D. Lakdawalla, and A. Chandra. 2011. “Malpractice Risk According to Physician Specialty.” New England Journal of Medicine 365: 629–36. https://doi.org/10.1056/nejmsa1012370.Search in Google Scholar

Kairies-Schwarz, N., and Souček, C. 2020. “Performance Pay in Hospitals: An Experiment on Bonus–Malus Incentives.” International Journal of Environmental Research and Public Health 17 (22): 1–30. https://doi.org/10.3390/ijerph17228320.Search in Google Scholar

Kellermann, A. L., and B. B. Hackman. 1990. “Patient ‘dumping’ Post-COBRA.” American Journal of Public Health 80 (7): 864–7. https://doi.org/10.2105/ajph.80.7.864.Search in Google Scholar

Kerschbamer, R., and M. Sutter. 2017. “The Economics of Credence Goods–A Survey of Recent Lab and Field Experiments.” CESifo Economic Studies 63 (1): 1–23. https://doi.org/10.1093/cesifo/ifx001.Search in Google Scholar

Kessler, D. P. 2011. “Evaluating the Medical Malpractice Systems and Options for Reform.” Journal of Economic Perspectives 25 (2): 93–110. https://doi.org/10.1257/jep.25.2.93.Search in Google Scholar

Kessler, D. P., and M. B. McClellan. 2002. “How Liability Law Affects Medical Productivity.” Journal of Health Economics 21 (6): 931–55. https://doi.org/10.1016/s0167-6296(02)00076-0.Search in Google Scholar

Lagarde, M., and D. Blaauw. 2017. “Physicians Respond to Financial and Social Incentives: A Medically Framed Real Effort Experiment.” Social Science & Medicine 179: 147–59. https://doi.org/10.1016/j.socscimed.2017.03.002.Search in Google Scholar

Li, X., Y. Zhang, X. Zhang, X. Li, X. Lin, and Y. Han. 2022. “Effects of Fee-For-Service, Diagnosis-Related-Group, and Mixed Payment Systems on Physicians’ Medical Service Behavior: Experimental Evidence.” BMC Health Services Research 22 (1): 1–12. https://doi.org/10.1186/s12913-022-08218-5.Search in Google Scholar

Lin, H. C., S. Kao, C. H. Tang, M. C. Yang, and H. S. Lee. 2006. “Factors Contributing to Patient Dumping in Taiwan.” Health Policy 77 (1): 103–12. https://doi.org/10.1016/j.healthpol.2005.07.009.Search in Google Scholar

Lin, T. F., and P. Schmidt. 1984. “A Test of the Tobit Specification against an Alternative Suggested by Cragg.” The Review of Economics and Statistics 66 (1): 174–7, https://doi.org/10.2307/1924712.Search in Google Scholar

Ma, C.-T. A. 1994. “Health Care Payment Systems: Cost and Quality Incentives.” Journal of Economics & Management Strategy 3: 93–112.Search in Google Scholar

Ma, C.-T. A., and H. Y. Mak. 2015. “Information Disclosure and the Equivalence of Prospective Payment and Cost Reimbursement.” Journal of Economic Behavior & Organization 117: 439–52. https://doi.org/10.1016/j.jebo.2015.07.002.Search in Google Scholar

Makris, M., and L. Siciliani. 2013. “Optimal Incentive Schemes for Altruistic Providers.” Journal of Public Economic Theory 15: 675–99. https://doi.org/10.1111/jpet.12047.Search in Google Scholar

Manski, C. F. 1977. “The Structure of Random Utility Models.” Theory and Decision 8 (3): 229. https://doi.org/10.1007/bf00133443.Search in Google Scholar

Martinsson, P., and E. Persson. 2019. “Physician Behavior and Conditional Altruism: The Effects of Payment System and Uncertain Health Benefit.” Theory and Decision 87 (3): 365–87. https://doi.org/10.1007/s11238-019-09714-7.Search in Google Scholar

Matsaganis, M., and H. Glennerster. 1994. “The Threat of ‘Cream Skimming’ in the Post-Reform NHS.” Journal of Health Economics 13 (1): 31–60. https://doi.org/10.1016/0167-6296(94)90003-5.Search in Google Scholar

Maynard, A., M. Marinker, and P. D. Gray. 1986. “The Doctor, the Patient, and their Contract.” BMJ 292: 1438–40. https://doi.org/10.1136/bmj.292.6533.1438.Search in Google Scholar

McGuire, T. G., and M. V. Pauly. 1991. “Physician Response to Fee Changes with Multiple Payers.” Journal of Health Economics 10 (4): 385–410. https://doi.org/10.1016/0167-6296(91)90022-f.Search in Google Scholar

McKeganey, N. 2001. “To Pay or Not to Pay: Respondents’ Motivation for Participating in Research.” Addiction 96 (9): 1237–8. https://doi.org/10.1046/j.1360-0443.2001.96912371.x.Search in Google Scholar

Mello, M. M., A. Chandra, A. A. Gawande, and D. M. Studdert. 2010. “National Costs of the Medical Liability System.” Health Affairs 29 (9): 1569–77. https://doi.org/10.1377/hlthaff.2009.0807.Search in Google Scholar

Newhouse, J.P. 1983. “Two Prospective Difficulties with Prospective Payment of Hospitals, or, It’s Better to be a Resident than a Patient with an Complex Problem.” Journal of Health Economics 2 (3): 269–74. https://doi.org/10.1016/s0167-6296(83)80006-x.Search in Google Scholar

Reif, S., L. Hafner, and M. Seebauer. 2020. “Physician Behavior under Prospective Payment Schemes—Evidence from Artefactual Field and Lab Experiments.” International Journal of Environmental Research and Public Health 17 (15): 1–37. https://doi.org/10.3390/ijerph17155540.Search in Google Scholar

Rice, M., W. Jones, and B. Rouge. 1988. “The Uninsured and Patient Dumping: Recent Policy Responses in Indigent Care.” Journal of the National Medical Association 83 (10): 874–80.Search in Google Scholar

Robinson, J. C. 2001. “Theory and Practice in the Design of Physician Payment Incentives.” The Milbank Quarterly 79 (2): 149–77. https://doi.org/10.1111/1468-0009.00202.Search in Google Scholar

Saks, S. J. 2004. “Call 911: Psychiatry and the New Emergency Medical Treatment and Active Labor Act (EMTALA) Regulations.” The Journal of Psychiatry & Law 32 (4): 483–512. https://doi.org/10.1177/009318530403200403.Search in Google Scholar

Sappington, D. E. M., and T. R. Lewis. 1999. “Using Subjective Risk Adjusting to Prevent Patient Dumping in the Health Care Industry.” Journal of Economics & Management Strategy 8 (3): 351–82. https://doi.org/10.1111/j.1430-9134.1999.00351.x.Search in Google Scholar

Schlesinger, M., R. Dorwart, C. Hoover, and S. Epstein. 1997. “The Determinants of Dumping: A National Study of Economically Motivated Transfers Involving Mental Health Care.” Health Services Research 32 (5): 561.Search in Google Scholar

Shurtz, I. 2014. “Malpractice Law, Physicians’ Financial Incentives, and Medical Treatment: How Do They Interact?” The Journal of Law and Economics 57 (1): 1–29. https://doi.org/10.1086/674408.Search in Google Scholar

Simoens, S., and A. Giuffrida. 2004. “The Impact of Physician Payment Methods on Raising the Efficiency of the Healthcare System.” Applied Health Economics and Health Policy 3 (1): 39–46. https://doi.org/10.2165/00148365-200403010-00008.Search in Google Scholar

Studdert, D. M., M. M. Mello, W. Sage, W. M. DesRoches, C. M. Peugh, K. Zapert, and T. A. Brennan. 2005. “Defensive Medicine Among High-Risk Specialist Physicians in a Volatile Malpractice Environment.” JAMA 293 (21): 2609–17. https://doi.org/10.1001/jama.293.21.2609.Search in Google Scholar

Traina, F. 2009. “Medical Malpractice: The Experience in Italy.” Clinical Orthopaedics and Related Research 467 (2): 434–42. https://doi.org/10.1007/s11999-008-0582-z.Search in Google Scholar

Treiger, K. I. 1986. “Preventing Patient Dumping: Sharpening the Cobra’s Fangs.” New York University Law Review 61: 1186.Search in Google Scholar

U.S. Commission on Civil Rights. 2014. Patient Dumping Statutory Enforcement Report. http://www.eusccr.com/patient_dumping.html (accessed January 4, 2023).Search in Google Scholar

Waibel, C., and D. Wiesen. 2021. “An Experiment on Referrals in Health Care.” European Economic Review 131: 103612. https://doi.org/10.1016/j.euroecorev.2020.103612.Search in Google Scholar

Wang, J., T. Iversen, H. Hennig-Schmidt, and G. Godager. 2020. “Are Patient-Regarding Preferences Stable? Evidence from a Laboratory Experiment with Physicians and Medical Students from Different Countries.” European Economic Review 125: 103411. https://doi.org/10.1016/j.euroecorev.2020.103411.Search in Google Scholar

Zibulewsky, J. 2001. “The Emergency Medical Treatment and Active Labor Act (EMTALA): What it is and what it Means for Physicians.” Baylor University Medical Center Proceedings 14 (4): 339–46. https://doi.org/10.1080/08998280.2001.11927785.Search in Google Scholar

Zuabi, N., L. D. Weiss, and M. I. Langdorf. 2016. “Emergency Medical Treatment and Labor Act (EMTALA) 2002–15: Review of Office of Inspector General Patient Dumping Settlements.” Western Journal of Emergency Medicine 17 (3): 245. https://doi.org/10.5811/westjem.2016.3.29705.Search in Google Scholar

Received: 2022-11-22
Accepted: 2023-11-22
Published Online: 2023-12-11

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 21.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/bejeap-2022-0419/html?lang=en
Scroll to top button